Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis

被引：33

作者：

Hidaka, Y ^{[1
]}

Okumura, M ^{[1
]}

Shimaoka, Y ^{[1
]}

Takeoka, K ^{[1
]}

Tada, H ^{[1
]}

Amino, N ^{[1
]}

机构：

[1] Osaka Univ, Sch Med, Dept Lab Med, Suita, Osaka 565, Japan

来源：

THYROID | 1998年 / 8卷 / 03期

关键词：

D O I：

10.1089/thy.1998.8.235

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We investigated serum levels of interleukin-5 (IL-5) in order to examine the role of T-helper 2 (Th2)-type immune response in the pathogenesis of autoimmune thyroid diseases. Serum levels of IL-5 were determined by a highly sensitive sandwich enzyme-linked immunosorbent assay in 42 patients with Graves' disease, 32 patients with Hashimoto's thyroiditis, 12 patients with silent thyroiditis, and 21 normal controls. Compared with serum levels in normal subjects (5.8 +/- 4.2 pg/mL), IL-5 was increased in patients with Graves' disease (16.4 +/- 16.7 pg/mL, p < .01), and in patients with Hashimoto's thyroiditis (10.0 +/- 7.6 pg/mL, p < .05), but not in patients with silent thyroiditis. There was no correlation between serum free thyroxine (FT4) and IL-5 levels. These data suggest an important role of the Th2-type immune response in the pathogenesis of Graves' disease and Hashimoto's thyroiditis.

引用

页码：235 / 239

页数：5

共 19 条

[1] New frontiers for IL-5 [J].

Bagley, CJ ;

Lopez, AF ;

Vadas, MA .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (06) :725-728

[2] SERUM LEVELS OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA IN HYPERTHYROID PATIENTS BEFORE AND AFTER PROPYLTHIOURACIL TREATMENT [J].

CELIK, I ;

AKALIN, S ;

ERBAS, T .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (06) :668-672

[3] CD4 T-LYMPHOCYTE ACTIVATION IN ASTHMA IS ACCOMPANIED BY INCREASED SERUM CONCENTRATIONS OF INTERLEUKIN-5 - EFFECT OF GLUCOCORTICOID THERAPY [J].

CORRIGAN, CJ ;

HACZKU, A ;

GEMOUENGESAETH, V ;

DOI, S ;

KIKUCHI, Y ;

TAKATSU, K ;

DURHAM, SR ;

KAY, AB .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (03) :540-547

[4] Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR) [J].

Heuer, M ;

Aust, G ;

OdeHakim, S ;

Scherbaum, WA .

THYROID, 1996, 6 (02) :97-106

[5] RECURRENCE OF THYROTOXICOSIS AFTER ATTACK OF ALLERGIC RHINITIS IN PATIENTS WITH GRAVES-DISEASE [J].

HIDAKA, Y ;

AMINO, N ;

IWATANI, Y ;

ITOH, E ;

MATSUNAGA, M ;

TAMAKI, H .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1667-1670

[6]

HIDAKA Y, 1996, THYROID, V6, P347

[7]

IWATANI Y, 1989, CLIN EXP IMMUNOL, V78, P196

[8] Serum interleukin-6 and bone metabolism in patients with thyroid function disorders [J].

Lakatos, P ;

Foldes, J ;

Horvath, C ;

Kiss, L ;

Tatrai, A ;

Takacs, I ;

Tarjan, G ;

Stern, PH .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :78-81

[9] Hyperthyroidism [J].

Lazarus, JH .

LANCET, 1997, 349 (9048) :339-343

[10] The expanding universe of T-cell subsets: Th1, Th2 and more [J].

Mosmann, TR ;

Sad, S .

IMMUNOLOGY TODAY, 1996, 17 (03) :138-146

← 1 2 →